=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-05-15
10b5-1 Pre-arranged Plan: Yes
--- Issuer ---
Name: GILEAD SCIENCES, INC. (GILD)
CIK: 0000882095
--- Reporting Owner ---
Name: Mercier Johanna
CIK: 0001782135
Role: Officer (Chief Comm & Corp Aff Officer)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-05-15 | Code: M (Exercise of derivative)
Shares: +25,000 | Price: $66.64
Total Value: $1,666,000.00
Shares Owned After: 153,779 | Ownership: D (Direct)
Footnotes:
[F1] The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
[Transaction #2]
Security: Common Stock
Date: 2026-05-15 | Code: S (Open market sale)
Shares: -7,749 | Price: $130.29
Total Value: $1,009,628.83
Shares Owned After: 146,030 | Ownership: D (Direct)
Footnotes:
[F1] The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
[F2] Sale prices for the transactions reported range from $129.66 to $130.63. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
[Transaction #3]
Security: Common Stock
Date: 2026-05-15 | Code: S (Open market sale)
Shares: -11,177 | Price: $131.19
Total Value: $1,466,329.63
Shares Owned After: 134,853 | Ownership: D (Direct)
Footnotes:
[F1] The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
[F3] Sale prices for the transactions reported range from $130.67 to $131.505. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
[Transaction #4]
Security: Common Stock
Date: 2026-05-15 | Code: S (Open market sale)
Shares: -8,374 | Price: $132.23
Total Value: $1,107,314.12
Shares Owned After: 126,479 | Ownership: D (Direct)
Footnotes:
[F1] The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
[F4] Sale prices for the transactions reported range from $131.71 to $132.55. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
[Transaction #5]
Security: Common Stock
Date: 2026-05-15 | Code: S (Open market sale)
Shares: -700 | Price: $132.75
Total Value: $92,925.98
Shares Owned After: 125,779 | Ownership: D (Direct)
Footnotes:
[F1] The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
[F5] Sale prices for the transactions reported range from $132.74 to $132.78. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
--- Derivative Transactions ---
[Transaction #1]
Security: Non-qualified Stock Option (Right to Buy)
Date: 2026-05-15 | Code: M (Exercise of derivative)
Shares: -25,000 | Price: $0.00
Exercisable: N/A | Expires: 2029-07-24
Shares Owned After: 23,110 | Ownership: D (Direct)
Footnotes:
[F1] The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
[F6] The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
--- Footnotes (Complete Index) ---
F1: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
F2: Sale prices for the transactions reported range from $129.66 to $130.63. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
F3: Sale prices for the transactions reported range from $130.67 to $131.505. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
F4: Sale prices for the transactions reported range from $131.71 to $132.55. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
F5: Sale prices for the transactions reported range from $132.74 to $132.78. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
F6: The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
--- Signature ---
/s/ /s/ Amy Kim by Power of Attorney for Johanna Mercier (2026-05-18)
